Halofuginone inhibits NF-kappaB and p38 MAPK in activated T cells.
Leiba M, Cahalon L, Shimoni A, Lider O, Zanin-Zhorov A, Hecht I, Sela U, Vlodavsky I, Nagler A.
Leiba M, et al. Among authors: nagler a.
J Leukoc Biol. 2006 Aug;80(2):399-406. doi: 10.1189/jlb.0705409. Epub 2006 Jun 12.
J Leukoc Biol. 2006.
PMID: 16769768